Webinar Recap: AI Agents and Patient-Level Data – From Confirmation of Diagnosis to Insights
AI research agents are no longer theoretical in rare disease and oncology—they’re starting to reshape how teams find patients, understand journeys, and generate evidence. That reality came through clearly in our recent joint webinar with Rare Patient Voice, “AI Agents and Patient-Level Data: From Confirmation of Diagnosis to Insights.” Setting the stage: disruption, data, […]
The Three Pillars of High-Impact AI in Rare Diseases & Oncology
For rare diseases and oncology, where data is scarce and patients are hard to find, the margin for error is razor-thin. We believe achieving success with AI requires a strategic commitment to three core pillars: The Right Data Foundation with Integrated Patient Data™: Finding quality data in Oncology & Rare Diseases has always been a […]
Enhancing FDA’s Patient-Focused Drug Development: Leveraging Clinakos’ Integrated Patient Data™ and Medically Smart AI™ for a Competitive Advantage
As the pharmaceutical industry transitions to a patient-centric model, real-world data is increasingly used to inform drug development and regulatory decisions. Including the perspectives of patients, caregivers, and advocates in drug development enhances clinical trial design, endpoint selection, and regulatory review processes. This strategy, where patient voice is not an afterthought, aims to focus research […]
